An Open-label, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous Infusions of ATB200 Alone and ATB200 Co-administered with Oral AT2221 in Adu

Administered By

Awarded By

Contributors

Start/End

  • May 9, 2018 - 2020-04-30